Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -88.72% is 40% below its 3-year average of -63.38%, near the low end of its 3-year range (-103.90%–-34.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.07% below its 12-month average of -67.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -88.72%.
RETURN ON INVESTED CAPITAL (ROIC)
-88.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-67.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-63.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.07%
CURRENT VS 3Y AVG
-39.99%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
-180.59%
vs the sector median at left
Citius Oncology, Inc.
Market Cap
$81.82M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-67.69%
3Y Avg
-63.38%
5Y Avg
N/A
Market Cap
$81.67M
Return on Invested Capital (ROIC)
-16.28%
TTM Avg
-50.22%
3Y Avg
-41.74%
5Y Avg
-37.86%
Market Cap
$81.31M
Return on Invested Capital (ROIC)
-48.39%
TTM Avg
-44.64%
3Y Avg
-40.56%
5Y Avg
-32.79%
Market Cap
$80.49M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$84.17M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$84.52M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$84.87M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$85.18M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$85.90M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $81.82M | -88.72% | -67.69% | -63.38% | N/A |
| LENSAR Inc (LNSR)vs › | $81.67M | -16.28% | -50.22% | -41.74% | -37.86% |
| Pulmonx Corporation (LUNG)vs › | $81.31M | -48.39% | -44.64% | -40.56% | -32.79% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $80.49M | -836.58% | -213.85% | -158.30% | -121.35% |
| MediciNova, Inc. (MNOV)vs › | $84.17M | -31.62% | -27.86% | -23.01% | -20.58% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.52M | -100.35% | -639.99% | -358.78% | -266.51% |
| Humacyte, Inc. (HUMA)vs › | $84.87M | -90.27% | -103.33% | -85.38% | -72.83% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.18M | -88.28% | -61.59% | -48.92% | -67.61% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.90M | -109.43% | -208.02% | -178.83% | -203.50% |
| Conexeu Sciences Inc. (CNXU)vs › | $86.43M | N/A | N/A | N/A | N/A |
ROIC
-88.7%
ROE
-114.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -88.72% |
| 2026-03-31 | -103.90% |
| 2025-12-31 | -34.29% |
| 2025-09-30 | -45.72% |
| 2025-06-30 | -65.81% |
| 2025-03-31 | -60.35% |
| 2024-12-31 | -47.54% |
| 2024-09-30 | -39.82% |
| 2024-06-30 | -101.79% |
| 2024-03-31 | -79.40% |
| 2023-12-31 | -62.43% |
| 2023-09-30 | -45.42% |
| 2023-06-30 | -48.69% |
